LP
LMR Partners’s Neurocrine Biosciences NBIX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-47,740
| Closed | -$5.5M | – | 957 |
|
|
2024
Q3 | $5.5M | Buy |
+47,740
| New | +$5.5M | 0.04% | 182 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 880 |
|
|
2024
Q1 | – | Sell |
-2,905
| Closed | -$383K | – | 899 |
|
|
2023
Q4 | $383K | Hold |
2,905
| – | – | ﹤0.01% | 375 |
|
|
2023
Q3 | $327K | Hold |
2,905
| – | – | ﹤0.01% | 403 |
|
|
2023
Q2 | $274K | Hold |
2,905
| – | – | ﹤0.01% | 445 |
|
|
2023
Q1 | $294K | Hold |
2,905
| – | – | ﹤0.01% | 786 |
|
|
2022
Q4 | $347K | Sell |
2,905
-2,095
| -42% | -$250K | 0.01% | 918 |
|
|
2022
Q3 | $531K | Buy |
+5,000
| New | +$531K | 0.01% | 841 |
|
|
2019
Q4 | – | Sell |
-46,767
| Closed | -$4.21M | – | 497 |
|
|
2019
Q3 | $4.21M | Buy |
46,767
+34,062
| +268% | +$3.07M | 0.21% | 73 |
|
|
2019
Q2 | $1.07M | Buy |
+12,705
| New | +$1.07M | 0.04% | 224 |
|
|
2018
Q4 | – | Sell |
-82,430
| Closed | -$10.1M | – | 434 |
|
|
2018
Q3 | $10.1M | Buy |
+82,430
| New | +$10.1M | 0.64% | 43 |
|
|
2016
Q3 | – | Sell |
-57,800
| Closed | -$2.63M | – | 434 |
|
|
2016
Q2 | $2.63M | Buy |
+57,800
| New | +$2.63M | 0.41% | 70 |
|